Bvm Pharma Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
- Paid Up Capital ₹ 2.50 M
- Company Age 12 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth %
- Ebitda
- Net Worth -0.41%
- Total Assets -0.26%
About Bvm Pharma
Bvm Pharma Limited (BPL) is a Public Limited Indian Non-Government Company incorporated in India on 09 November 2012 and has a history of 12 years and two months. Its registered office is in Greater Noida, Uttar Pradesh.
The Company is engaged in the Business Outsourcing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 2.50 M, as per Ministry of Corporate Affairs (MCA) records.
Amit Singh, Omvir Singh, and Balakrishnan Dananjayan serve as directors at the Company.
Company Details
-
LocationGreater Noida, Uttar Pradesh
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74120UP2012PLC053599
-
Company No.
053599
-
Company Classification
Public Limited Indian Non-Government Company
-
Incorporation Date
09 Nov 2012
-
Date of AGM
21 Aug 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Bvm Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Singh
|
Additional Director | 16-Sep-2013 | Current |
|
Omvir Singh
|
Additional Director | 20-Jan-2013 | Current |
|
Balakrishnan Dananjayan
|
Director | 09-Nov-2012 | Current |
Financial Performance of Bvm Pharma.
Bvm Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth dipped by a decrease of 0.41%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bvm Pharma?
In 2023, Bvm Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Scilla Biotechnologies LimitedAmit Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bvm Pharma?
Unlock and access historical data on people associated with Bvm Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bvm Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bvm Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
